Details for New Drug Application (NDA): 217197
✉ Email this page to a colleague
The generic ingredient in ACETAZOLAMIDE is acetazolamide sodium. There are ten drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the acetazolamide sodium profile page.
Summary for 217197
Tradename: | ACETAZOLAMIDE |
Applicant: | Ne Rx Pharma |
Ingredient: | acetazolamide |
Patents: | 0 |
Pharmacology for NDA: 217197
Mechanism of Action | Carbonic Anhydrase Inhibitors |
Medical Subject Heading (MeSH) Categories for 217197
Suppliers and Packaging for NDA: 217197
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ACETAZOLAMIDE | acetazolamide | TABLET;ORAL | 217197 | ANDA | Aarkish Pharmaceuticals NJ Inc. | 81005-104 | 81005-104-01 | 100 TABLET in 1 BOTTLE (81005-104-01) |
ACETAZOLAMIDE | acetazolamide | TABLET;ORAL | 217197 | ANDA | Aarkish Pharmaceuticals NJ Inc. | 81005-104 | 81005-104-10 | 1000 TABLET in 1 BOTTLE (81005-104-10) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 125MG | ||||
Approval Date: | May 9, 2023 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 250MG | ||||
Approval Date: | May 9, 2023 | TE: | AB | RLD: | No |
Complete Access Available with Subscription